Journal
RESVERATROL AND HEALTH
Volume 1215, Issue -, Pages 103-108Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1749-6632.2010.05865.x
Keywords
stilbenoid; Alzheimer's disease; beta-amyloid peptide; inhibition of aggregation
Categories
Ask authors/readers for more resources
Stilbenoid compounds consist of a family of resveratrol derivatives. They have demonstrated promising activities in vitro and in vivo that indicate they may be useful in the prevention of a wide range of pathologies, such as cardiovascular diseases and cancers, as well have anti-aging effects. More recently stilbenoid compounds have shown promise in the treatment and prevention of neurodegenerative disorders, such as Huntington's, Parkinson's, and Alzheimer's diseases. This paper primarily focuses on the impact of stilbenoids in Alzheimer's disease and more specifically on the inhibition of beta-amyloid peptide aggregation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available